chr17-3679624-C-T
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_002561.4(P2RX5):c.1225G>A(p.Gly409Arg) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000046 in 1,608,756 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/21 in silico tools predict a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Consequence
NM_002561.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
P2RX5 | NM_002561.4 | c.1225G>A | p.Gly409Arg | missense_variant | 11/12 | ENST00000225328.10 | NP_002552.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
P2RX5 | ENST00000225328.10 | c.1225G>A | p.Gly409Arg | missense_variant | 11/12 | 1 | NM_002561.4 | ENSP00000225328.5 | ||
P2RX5 | ENST00000697413.1 | c.1291G>A | p.Gly431Arg | missense_variant | 12/13 | ENSP00000513301.1 | ||||
P2RX5-TAX1BP3 | ENST00000550383.1 | n.1225G>A | non_coding_transcript_exon_variant | 11/15 | 2 | ENSP00000455681.1 |
Frequencies
GnomAD3 genomes AF: 0.0000460 AC: 7AN: 152138Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.0000606 AC: 15AN: 247688Hom.: 0 AF XY: 0.0000745 AC XY: 10AN XY: 134254
GnomAD4 exome AF: 0.0000460 AC: 67AN: 1456618Hom.: 0 Cov.: 32 AF XY: 0.0000441 AC XY: 32AN XY: 724902
GnomAD4 genome AF: 0.0000460 AC: 7AN: 152138Hom.: 0 Cov.: 33 AF XY: 0.0000538 AC XY: 4AN XY: 74312
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Sep 11, 2024 | The c.1225G>A (p.G409R) alteration is located in exon 11 (coding exon 11) of the P2RX5 gene. This alteration results from a G to A substitution at nucleotide position 1225, causing the glycine (G) at amino acid position 409 to be replaced by an arginine (R). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at